A leader from the mobile research nursing specialist offers advice on what to look for in a service provider, and why finding the right one is vital. With COVID-19 causing a surge in decentralized trials, pharmaceutical firms and their research teams increasingly are looking to qualified technology and service providers to help bring the studies to the patients, in their homes. Gerard Barron, vice president of operations for Illingworth Research Group, a Syneos Health Company, spoke with Outsourcing-Pharma about how to choose qualified providers, and why joining forces with the right company can make a significant difference. OSP: Could you please share your perspective on how decentralized trial (DCT) technology has evolved in recent years?